Skip to main content
SpringerLink
Log in

Is there a recommended maximum starting dose of FSH in IVF?

  • Assisted Reproduction
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

This report reviews and discusses the existing evidence on recommended FSH doses in IVF cycles. A comprehensive search for relevant data was performed in the Cochrane Library, MEDLINE, EMBASE and NICE clinical guidelines database, and the reference lists of manuscripts. A good body of evidence exists looking at starting doses of FSH for first IVF attempts. Only one randomised controlled trial was identified looking at the efficacy of increasing doses during an IVF cycle. Some observational studies dealt with the question whether a suboptimal ovarian response should be managed by an increased FSH dose in a subsequent cycle, but no randomised trials addressed this issue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Trounson AO, Leeton JF, Wood C, Webb J, Wood J. Pregnancies in humans by fertilization in vitro and embryo transfer in the controlled ovulatory cycle. Science 1981;212:681–2.

    Article  PubMed  CAS  Google Scholar 

  2. Pelinck MJ, Hoek A, Simons AH, Heineman MJ. Efficacy of natural cycle IVF: a review of the literature. Hum Reprod Updat 2002;8:129–39.

    Article  CAS  Google Scholar 

  3. National Collaborating Centre for Women’s and Children’s Health. Fertility: assessment and treatment for people with fertility problems. Commissioned by the National Institute for Clinical Excellence. London: RCOG Press; 2004. p. 60–1.

    Google Scholar 

  4. Norman RJ, de Lacey S, Wang JX. Recombinant or urinary gonadotrophins—an Australian perspective. Reprod Biomed Online 2005;11:542–3.

    Article  PubMed  CAS  Google Scholar 

  5. Scott RT Jr. Diminished ovarian reserve and access to care. Fertil Steril 2004;81:1489–92.

    Article  PubMed  Google Scholar 

  6. Surrey ES, Schoolcraft WB. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril 2000;73:667–76.

    Article  PubMed  CAS  Google Scholar 

  7. Macklon NS, Stouffer RL, Giudice LC, Fauser BC. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev 2006;27:170–207.

    Article  PubMed  Google Scholar 

  8. Popovic-Todorovic B, Loft A, Bredkjæer HE, Bangsboll S, Nielsen IK, Andersen AN. A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a ‘standard’ dose of 150 IU/day in ‘standard’ patients undergoing IVF/ICSI treatment. Hum Reprod 2003;18:2275–82.

    Article  PubMed  CAS  Google Scholar 

  9. Tan SL, Child TJ, Cheung AP, Fluker MR, Yuzpe A, Casper R, et al. A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon®) in women undergoing controlled ovarian hyperstimulation for IVF treatment. J Assist Reprod Genet 2005;22:81–8.

    Article  PubMed  Google Scholar 

  10. Out HJ, Lindenberg S, Mikkelsen AL, Eldar-Geva T, Healy DL, Leader A, et al. A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon®) in women undergoing ovarian stimulation. Hum Reprod 1999;14:622–7.

    Article  PubMed  CAS  Google Scholar 

  11. Out HJ, David I, Ron-El R, Friedler S, Shalev E, Geslevich J, et al. A randomized, double-blind clinical trial using fixed daily doses of 100 or 200 IU of recombinant FSH in ICSI cycles. Hum Reprod 2001;16:1104–49.

    Article  PubMed  CAS  Google Scholar 

  12. Pruksananonda K, Suwajanakorn S, Sereepapong W, Virutamasen P. Comparison of two different fixed doses of follitropin-beta in controlled ovarian hyperstimulation: a prospective randomized, double blind clinical trial. J Med Assoc Thail 2004;87:1151–5.

    Google Scholar 

  13. Hoomans EH, Mulder BB. Asian Purgeon Study Group. A group-comparative, randomized, double-blind comparison of the efficacy and efficiency of two fixed daily dose regimens (100- and 200-IU) of recombinant follicle stimulating hormone (rFSH, Puregon) in Asian women undergoing ovarian stimulation for IVF/ICSI. J Assist Reprod Genet 2002;19:470–6.

    Article  PubMed  Google Scholar 

  14. Out HJ, Braat DD, Lintsen BM, Gurgan T, Bukulmez O, Gokmen O, et al. Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation. Hum Reprod 2000;15:29–35.

    Article  PubMed  CAS  Google Scholar 

  15. Yong PY, Brett S, Baird DT, Thong KJ. A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment. Fertil Steril 2003;79:308–15.

    Article  PubMed  Google Scholar 

  16. Latin-American Puregon IVF Study Group. A double-blind clinical trial comparing a fixed daily dose of 150 and 250 IU of recombinant follicle-stimulating hormone in women undergoing in vitro fertilization. Fertil Steril 2001;76:950–6.

    Article  Google Scholar 

  17. Out HJ, Rutherford A, Fleming R, Tay CC, Trew G, Ledger W, et al. A randomized, double-blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction. Hum Reprod 2004;19:90–5.

    Article  PubMed  Google Scholar 

  18. Wikland M, Bergh C, Borg K, Hillensjo T, Howles CM, Knutsson A, et al. A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI. Hum Reprod 2001;16:1676–81.

    Article  PubMed  CAS  Google Scholar 

  19. Klinkert ER, Broekmans FJ, Looman CW, Habbema JD, te Velde ER. Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial. Hum Reprod 2005;20:611–5.

    Article  PubMed  CAS  Google Scholar 

  20. Nyboe Andersen A, Humaidan P, Fried G, the Nordic rLH study group. Addition of rLH (Luveris) to rFSH during the final days of follicular maturation in IVF/ICSI treated patients. A Nordic randomized multicenter trial. Hum Reprod 2006;21(Suppl. 1):O-138.

    Google Scholar 

  21. Fleming R, on behalf of the “Luveris Pre-treatment Group.” Pre-treatment with rhLH: respective effects on antral follicular count and ovarian response to rhFSH. Hum Reprod 2006;21(Suppl. 1):O-139.

    Google Scholar 

  22. Van Hooff MH, Alberda AT, Huisman GJ, Zeilmaker GH, Leerentveld RA. Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study. Hum Reprod 1993;8:369–73.

    PubMed  CAS  Google Scholar 

  23. Hock DL, Louie H, Shelden RM, Ananth CV, Kemmann E. The need to step up the gonadotropin dosage in the stimulation phase of IVF treatment predicts a poor outcome. J Assist Reprod Genet 1998;15:427–30.

    PubMed  CAS  Google Scholar 

  24. Khalaf Y, el Tooukhy T, Taylor A, Braude P. Increasing the gonadotrophin dose in the first course of an in vitro fertilization cycle does not rectify an initial poor response. Eur J Obstet Gynaecol Reprod Biol 2002;103:146–9.

    Article  CAS  Google Scholar 

  25. Loutradis D, Drakakis P, Milingos S, Stefanidis K, Michalas S. Alternative approaches in the management of poor response in controlled ovarian hyperstimulation (COH). Ann N Y Acad Sci 2003;997:112–9.

    Article  PubMed  Google Scholar 

  26. National Collaborating Centre for Women’s and Children’s Health. Fertility: assessment and treatment for people with fertility problems. Commissioned by the National Institute for Clinical Excellence. London: RCOG Press; 2004. p. 102.

    Google Scholar 

  27. Klinkert ER, Broekmans FJ, Looman CW, Te Velde ER. A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles. Fertil Steril 2004;81:1247–53.

    Article  PubMed  Google Scholar 

  28. Karande VC, Jones GS, Beeck LL, Muasher SJ. High dose FSH stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low responder patients. Fertil Steril 1990;53:486–9.

    PubMed  CAS  Google Scholar 

  29. Pantos C, Thornton SJ, Speirs AL, Johnston I. Increasing the human menopausal gonadotropin dose—does the response really improve? Fertil Steril 1990;53:436–9.

    PubMed  CAS  Google Scholar 

  30. Land JA, Yarmolinskaya MI, Dumoulin JCM, Evers JLH. High-dose human menopausal gonadotrophin stimulation in poor responders does not improve in-vitro fertilization outcome. Fertil Steril 1996;65:961–5.

    PubMed  CAS  Google Scholar 

  31. Lashen H, Ledger W, Bernal AL, Evans B, Barlow D. Superovulation with a high dose for in vitro fertilization: is it effective? J Assist Reprod Genet 1998;15:438–43.

    PubMed  CAS  Google Scholar 

  32. Galton F. Regression towards mediocrity in hereditary stature. J Anthropol Inst 1886;15:246–63.

    Google Scholar 

  33. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Updat 2003;9:61–76.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynaecology, Monash University, Melbourne, Australia

    Luk Rombauts

  2. Monash IVF, 1/252 Clayton Rd., Clayton, Melbourne, Victoria, 3168, Australia

    Luk Rombauts

Authors
  1. Luk Rombauts
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luk Rombauts.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rombauts, L. Is there a recommended maximum starting dose of FSH in IVF?. J Assist Reprod Genet 24, 343–349 (2007). https://doi.org/10.1007/s10815-007-9134-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-007-9134-9

Keywords

Search

Navigation